207 results on '"Kotze, Paulo G."'
Search Results
2. Global Hospitalization Trends for Crohn’s Disease and Ulcerative Colitis in the 21st Century: A Systematic Review With Temporal Analyses
3. IOIBD Recommendations for Clinical Trials in Ulcerative Proctitis: The PROCTRIAL Consensus
4. Temporal trends in the epidemiology of inflammatory bowel diseases in the public healthcare system in Brazil: A large population-based study
5. Management of pouch neoplasia: consensus guidelines from the International Ileal Pouch Consortium
6. New insights on the surgical management of ulcerative colitis in the 21st century
7. Endpoints for extraintestinal manifestations in inflammatory bowel disease trials: the EXTRA consensus from the International Organization for the Study of Inflammatory Bowel Diseases
8. Therapeutic drug monitoring of biologics in inflammatory bowel disease: unmet needs and future perspectives
9. Diagnosis and classification of ileal pouch disorders: consensus guidelines from the International Ileal Pouch Consortium
10. Certolizumab Pegol in Crohn's Disease Management: A Multicentric Brazilian Observational Study
11. Association Between Smoking Status and the Efficacy and Safety of Tofacitinib in Patients with Ulcerative Colitis
12. Concomitant Use of Aminosalicylates Is Not Associated With Improved Outcomes in Patients With Ulcerative Colitis Escalated to Vedolizumab
13. Trends in hospitalisation rates for inflammatory bowel disease in western versus newly industrialised countries: a population-based study of countries in the Organisation for Economic Co-operation and Development
14. Correlation between trough levels of infliximab and postoperative endoscopic recurrence in Crohn’s disease patients submitted to ileocolonic resections
15. Correlation between trough levels of infliximab and postoperative endoscopic recurrence in Crohn's disease patients submitted to ileocolonic resections.
16. International Organization for the Study of IBD Recommendations for Surgery in Patients With IBD During the Coronavirus Disease 2019 Pandemic
17. 948 ETRASIMOD FOR THE TREATMENT OF ULCERATIVE COLITIS: UP TO 2.5 YEARS OF POOLED SAFETY DATA FROM GLOBAL CLINICAL TRIALS
18. Development of the global inflammatory bowel disease visualization of epidemiology studies in the 21st century (GIVES-21)
19. The globalization of inflammatory bowel disease: the incidence and prevalence of inflammatory bowel disease in Brazil
20. Presence of risk factors associated with colectomy among patients with ulcerative colitis: a post hoc analysis of data from the tofacitinib OCTAVE ulcerative colitis clinical program
21. S962 Presence of Risk Factors Associated With Colectomy Among Patients With Colectomy in the Tofacitinib OCTAVE Ulcerative Colitis Clinical Program
22. Global Hospitalization Trends for Crohn’s Disease and Ulcerative Colitis in the 21st Century: A Systematic Review With Temporal Analyses
23. The Global Incidence of Peptic Ulcer Disease Is Decreasing Since the Turn of the 21st Century: A Study of the Organisation for Economic Co-Operation and Development (OECD)
24. Sa1556: GLOBAL HOSPITALIZATION TRENDS FOR FLARING CROHN'S DISEASE AND ULCERATIVE COLITIS: SYSTEMATIC REVIEW WITH TEMPORAL ANALYSES
25. Mo1486: MANAGEMENT OF POUCH NEOPLASIA: A CONSENSUS GUIDELINE FROM THE INTERNATIONAL ILEAL POUCH CONSORTIUM
26. Twenty-first Century Trends in the Global Epidemiology of Pediatric-Onset Inflammatory Bowel Disease: Systematic Review
27. 547 INCIDENCE AND PREVALENCE OF INFLAMMATORY BOWEL DISEASES IN HISPANICS IN THE UNITED STATES, 2011-2020
28. 1096 ENVIRONMENTAL AND DIETARY FACTORS IN INFLAMMATORY BOWEL DISEASE: A POPULATION-BASED CASE-CONTROL STUDY FROM THE GLOBAL INFLAMMATORY BOWEL DISEASE VISUALIZATION OF EPIDEMIOLOGY STUDIES IN THE 21ST CENTURY (GIVES-21) CONSORTIUM
29. Tu1863 INCIDENCE AND PHENOTYPE OF INFLAMMATORY BOWEL DISEASE IN 16 REGIONS ACROSS ASIA, AFRICA, LATIN AMERICA AND MIDDLE EAST FROM GIVES-21 CONSORTIUM
30. Temporal Trends in the Epidemiology of Inflammatory Bowel Diseases in the Public Healthcare System in Brazil: A Large Population-Based Study
31. International consensus on the prevention of venous and arterial thrombotic events in patients with inflammatory bowel disease
32. COVID‐19 outcomes in patients with inflammatory bowel diseases in Latin America: Results from SECURE‐IBD registry
33. The impact of body mass index on efficacy and safety in the tofacitinib OCTAVE ulcerative colitis clinical programme
34. sj-docx-1-tag-10.1177_17562848211005708 – Supplemental material for Extraintestinal manifestations at baseline, and the effect of tofacitinib, in patients with moderate to severe ulcerative colitis
35. Sa506 GLOBAL HOSPITALIZATION TRENDS FOR CROHN'S DISEASE AND ULCERATIVE COLITIS: SYSTEMATIC REVIEW WITH TEMPORAL ANALYSES
36. Adjunctive Hyperbaric Oxygen Therapy in Refractory Crohn’s Disease: An Observational Study
37. Extraintestinal manifestations at baseline, and the effect of tofacitinib, in patients with moderate to severe ulcerative colitis
38. Tu1755 HIGHER MAINTENANCE INFLIXIMAB CONCENTRATION IS ASSOCIATED WITH FAVORABLE THERAPEUTIC OUTCOMES IN PATIENTS WITH PERIANAL FISTULIZING CROHN'S DISEASE
39. Tu1238 SAFETY AND EFFECTIVENESS OF USTEKINUMAB THERAPY FOR ULCERATIVE COLITIS: A BRAZILIAN MULTICENTER REAL-WORLD STUDY
40. Sa1770 THE GLOBAL EVOLUTION OF INFLAMMATORY BOWEL DISEASE ACROSS FOUR EPIDEMIOLOGIC STAGES: A SYSTEMATIC REVIEW OF INCIDENCE AND PREVALENCE STUDIES OVER THE PAST CENTURY
41. Letter: thromboembolic and cardiovascular events with tofacitinib in ulcerative colitis-two cases in real world clinical practice
42. 279 COMBINATION THERAPY DOES NOT IMPROVE CLINICAL AND ENDOSCOPIC REMISSION RATES WITH VEDOLIZUMAB OR USTEKINUMAB IN CROHN'S DISEASE AND ULCERATIVE COLITIS
43. Tu1868 THE EFFECT OF TOFACITINIB ON EXTRAINTESTINAL MANIFESTATIONS AT BASELINE IN PATIENTS WITH MODERATE TO SEVERE ULCERATIVE COLITIS IN THE OCTAVE PROGRAM
44. Surgery for Inflammatory Bowel Disease Has Unclear Impact on Female Fertility: A Cochrane Collaboration Systematic Review
45. Letter: is measurement of faecal biomarkers helpful for the early diagnosis and prediction of pouchitis after proctocolectomy for ulcerative colitis?
46. ECCO-ESGAR guideline for diagnostic assessment in IBD part 1: initial diagnosis, monitoring of known IBD, detection of complications
47. ECCO-ESGAR Guideline for Diagnostic Assessment in Inflammatory Bowel Disease Part 1. Initial diagnosis, monitoring of known IBD, detections of complications
48. Perioperative dietary therapy in inflammatory bowel disease. Journal of Crohn and Colitis
49. Trends in hospitalisation rates for inflammatory bowel disease in western versus newly industrialised countries : a population-based study of countries in the Organisation for Economic Co-operation and Development
50. Trends in hospitalisation rates for inflammatory bowel disease in western versus newly industrialised countries:a population-based study of countries in the Organisation for Economic Co-operation and Development
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.